Showing results (71-80 of 103) with videos related to
Sort By:
Pageof 11
Lung|July 6, 2022
Cytomegalovirus Infection Is Associated with Development of Chronic Lung Allograft DysfunctionDavid Bennett, Laura Bergantini, Pierluigi Ferrara, et al.ACS Medicinal Chemistry Letters|May 14, 2025
Discovery of p-Trifluoromethylbenzohydrazide Derivatives as Potent Antiviral Agents against Monkeypox VirusSara Rossi, Luca Pozzetti, Gabriele Carullo, et al.Advances in Hematology|May 18, 2012
EBV Reactivation and Chromosomal Polysomies: Euphorbia tirucalli as a Possible Cofactor in Endemic Burkitt LymphomaSusanna Mannucci, Anna Luzzi, Alessandro Carugi, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 16, 2008
Chemotherapeutic drugs may be used to enhance the killing efficacy of human tumor antigen peptide-specific CTLsPierpaolo Correale, Maria Teresa Del Vecchio, Marco La Placa, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
High-affinity HLA-A(*)02.01 peptides from parathyroid hormone-related protein generate in vitro and in vivo antitumor CTL response without autoimmune side effectsGuido Francini, Antonio Scardino, Kostas Kosmatopoulos, et al.Microorganisms|February 25, 2022
Validation of Two Commercial Multiplex Real-Time PCR Assays for Detection of SARS-CoV-2 in Stool Donors for Fecal Microbiota TransplantationVincenzo Di Pilato, Fabio Morecchiato, Cosmeri Rizzato, et al.Cancer Letters|February 23, 2008
Anti-angiogenetic effects of immune-reconstituted influenza virosomes assembled with parathyroid hormone-related protein derived peptide vaccinePierpaolo Correale, Maria Teresa Del Vecchio, Tommaso Renieri, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Immune-reconstituted influenza virosome containing CD40L gene enhances the immunological and protective activity of a carcinoembryonic antigen anticancer vaccineMaria Grazia Cusi, Maria Teresa Del Vecchio, Chiara Terrosi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2008
Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial)Pierpaolo Correale, Pierosandro Tagliaferri, Antonella Fioravanti, et al.International Journal of Cancer|February 14, 2003
Treatment of colon and breast carcinoma cells with 5-fluorouracil enhances expression of carcinoembryonic antigen and susceptibility to HLA-A(*)02.01 restricted, CEA-peptide-specific cytotoxic T cells in vitroPierpaolo Correale, Angelo Aquino, Anna Giuliani, et al.Pageof 11